Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Karolinska Development Cash from Investing (TTM): -3.475M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -3.475M |
December 31, 2023 | -1.887M |
September 30, 2023 | 3.050M |
June 30, 2023 | -3.868M |
March 31, 2023 | -6.356M |
December 31, 2022 | -11.35M |
September 30, 2022 | -12.44M |
June 30, 2022 | -8.268M |
March 31, 2022 | -9.587M |
December 31, 2021 | -5.778M |
September 30, 2021 | -8.465M |
June 30, 2021 | -3.029M |
March 31, 2021 | 6.361M |
December 31, 2020 | 6.292M |
September 30, 2020 | 11.31M |
June 30, 2020 | 9.412M |
March 31, 2020 | 5.049M |
December 31, 2019 | 6.060M |
September 30, 2019 | -1.197M |
June 30, 2019 | -2.236M |
March 31, 2019 | -1.420M |
December 31, 2018 | -1.914M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | 12.82M |
March 31, 2013 | 68.54M |
December 31, 2012 | 24.30M |
September 30, 2012 | 25.64M |
June 30, 2012 | 24.49M |
March 31, 2012 | -69.56M |
December 31, 2011 | -66.40M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-12.44M
Minimum
Sep 2022
11.31M
Maximum
Sep 2020
-1.52M
Average
-2.632M
Median
Cash from Investing (TTM) Benchmarks
Abliva AB | -0.1218M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | -0.2606M |
Olink Holding AB | -22.43M |
BioInvent International AB | 24.48M |